Introduction {#Sec1}
============

Prostate cancer (PCa) is a public health problem worldwide. PCa is the most common malignant tumor in adult males, and the incidence rate is increasing^[@CR1]^. Moreover, PCa is the second leading cause of cancer death in men. Recently, diagnoses of PCa have relied on levels of prostate-specific antigen (PSA) and digital rectal examination (DRE), although pathologic histology remains the gold standard. However, these approaches potentially lead to under-diagnosis of PCa, whereas biopsy is an invasive method associated with patient discomfort and, in some cases, serious complications.

Although traditional grayscale transrectal ultrasonography (TRUS) is routinely used in diagnosis and to guide biopsy, it is not sufficiently sensitive or specific for biopsy procedures^[@CR2]^. Biopsy protocols should be optimized to accurately detect PCa while also reducing the number of prostate biopsy specimens and biopsy-related patient morbidity^[@CR3]^. The prostate gland is one of the earliest organs for which elastography was proposed and applied^[@CR4]^. PCa is stiffer than normal tissue because of its increased cellularity, which is sometimes found during DRE^[@CR5]--[@CR7]^. Transrectal elastosonography (TRES) has already been established to be feasible in guiding biopsies and for improving the detection of prostate lesions^[@CR8]--[@CR11]^.

Shear wave elastography (SWE) is a novel real-time imaging technique that represents a substantial advance in ultrasound elastography. When SWE is performed, the transducer automatically generates acoustic radiation force using a special "supersonic" speed that moves multiple focus points following the Mach cone principle. Tissue is then mechanically excited by the Mach cone impulse to generate small, localized tissue displacements (1--10 mm). These displacements have been tracked using a system to calculate the shear wave propagation speed and the quantitative tissue stiffness (i.e., Young's modulus, kPa)^[@CR12],\ [@CR13]^, which is defined as E = σ/ε, where σ is the applied stress and ε is the strain (the ratio of the resultant deformation of tissue over the original reference length of the medium)^[@CR14]^. Previous studies have established that the Young's modulus of PCa was significantly greater than that of benign prostatic tissue; the sensitivity ranged from 43% to 96.2%, and the specificity ranged from 69.1% to 96.2%^[@CR14]--[@CR20]^. However, there have been large differences among the results of different studies, and the cut-off value for adequate distinction between PCa and benign tissue remains undetermined. Additionally, another study found that SWE was a poor predictor of malignancy and that the cut-off value had little practical meaning^[@CR21]^. Therefore, the present study aimed to perform a meta-analysis to appraise the overall accuracy of SWE for the diagnosis of PCa.

Results {#Sec2}
=======

Characteristics of the included studies {#Sec3}
---------------------------------------

An electronic search identified 286 records. After screening titles and abstracts, we identified 34 studies for full text review. Among these articles, we classified 16 as review articles, 3 as comments, and 5 as other detection methods, whereas 3 had insufficient data for calculation. Ultimately, 7 correlative studies were identified as eligible studies; these were published from 2012 to 2016 (Fig. [1](#Fig1){ref-type="fig"}). Among those studies, two were analyzed twice, one according to PSA groupings of 4--20 μg/L and over 20 μg/L and one according to the ultrasonography section (axial vs. sagittal). Ultimately, data from 9 groups were included in this meta-analysis. Additionally, only one study referred to the transition zone, which is rare for PCa, and partial data were not included in the statistical analysis. Among these studies, 2 evaluated the diagnostic accuracy of SWE compared with the histopathology of radical prostatectomy (RP) specimens as a reference standard, whereas 5 compared SWE with the histopathology of TRUS biopsy specimens. The patient clinical features and essential data are summarized in Table [1](#Tab1){ref-type="table"}.Figure 1Literature search and selection scheme. Table 1Characteristics of the included studies.First authorYearCountryAge (avg)PSA (μg/L)Number of patientsNumber of samplesUltrasound systemCut-off value (kPa)TPFNFPTN1Zhang Mo2015China70.2114.52489NASupersonic Imagine Aixplorer28.519625372312.1Sarfraz Ahmad2013UK694--2039485SuperSonic Imagine, Aix-en-ProvenceNA28629201502.2Sarfraz Ahmad2013UK69\>2011141SuperSonic Imagine, Aix-en-ProvenceNA10272303.1Olivier Rouvière2016France636.5NA251SuperSonic Imagine, Aix-en-Provence454540181483.2Olivier Rouvière2016France636.5NA227SuperSonic Imagine, Aix-en-Provence524428461094Richard G. Barr2012America64.25.0553318SuperSonic Imagine, Aix-en-Provence37251112815Katharina Boehm2014GermanyNA8.760322Aixplorer System5011427561256Sungmin Woo2014Korea6612.8871058SuperSonic Imagine, Aix-en-Provence43.934451887917Jean-Michel Correas2015France65.17.41841040SuperSonic Imagine351245137774Age (Avg.) = Average age of patients; TP = True positive; FN = False negative; FP = False positive; TN = True negative. Data from one study were divided into two groups according to the PSA level: 2.1 (4--20 μg/L) and 2.2 (over 20 μg/L). Data from the other studies were divided into two groups according to the ultrasonography section: 3.1 (axial section) and 3.2 (sagittal section).

Methodological quality assessment of the included studies {#Sec4}
---------------------------------------------------------

Quality evaluation results for the individual studies are shown in Table [2](#Tab2){ref-type="table"}. The overall risk of bias was low because the index test and reference test characterization were adequate in most studies, and only one equivocal result was reported. In two studies^[@CR15],\ [@CR17]^, it was unclear whether the pathologist was blinded to the SWE results. One study^[@CR14]^ used a previously determined cut-off value, which was based on clinical experience and reported in the literature as the SWE reference standard. Another study^[@CR19]^ found that SWE was limited as a tool to reliably differentiate benign from malignant prostate tissues.Table 2Quality assessment of the included studies.First AuthorRisk of BiasApplicability ConcernsPatient SelectionIndex TestReference StandardFlow and TimingPatient SelectionIndex TestReference StandardZhang MolowlowunclearlowlowlowlowSarfraz AhmadlowhighlowlowlowlowlowOlivier RouvièrelowlowlowlowlowlowlowRichard G. BarrlowlowunclearlowlowlowlowKatharina BoehmlowlowlowlowlowlowlowSungmin WoolowlowlowlowlowunclearlowJean-Michel CorreaslowlowlowlowlowlowlowThe table summarizes the risk of bias and applicability concerns.

Diagnostic accuracy {#Sec5}
-------------------

Statistical analysis revealed no heterogeneity arising from a threshold effect, and the Spearman correlation coefficient of sensitivity and 1-specificity was −0.533 (p = 0.139). Ultimately, the diagnostic accuracy of SWE for the diagnosis of PCa was computed based on a pooled sensitivity of 0.844 (95% confidence interval (CI): 0.696--0.927), pooled specificity of 0.860 (95% CI: 0.792--0.908), pooled positive likelihood ratio (PLR) of 6.017 (95% CI: 3.674--9.853), pooled negative likelihood ratio (NLR) of 0.182 (95% CI: 0.085--0.389), and pooled diagnostic odds ratio (DOR) of 33.069 (95% CI: 10.222--106.982). Forest plots of all indices are shown in Fig. [2](#Fig2){ref-type="fig"}. An overall high degree of accuracy was revealed by the summary receiver operating characteristic (SROC) curve with an area under the curve (AUC) of 0.91 (95% CI: 0.89--0.94) (Fig. [3](#Fig3){ref-type="fig"}). A Fagan nomogram was constructed to illustrate the pre- and post-test probability of SWE to predict PCa based on all 7 studies (Fig. [4](#Fig4){ref-type="fig"}). Without taking into account the results of SWE, a PCa episode had a 'pre-test' probability of 20% to be detected. With a SWE-positive result for the detection of PCa, there was a 60% 'post-test' probability of a subsequent PCa episode. With a negative SWE, the 'post-test' probability of PCa dropped to 4%.Figure 2Forest plots of the diagnostic accuracy of SWE in PCa. A = Sensitivity; B = Specificity; C = Positive likelihood ratio; D = Negative likelihood ratio; E = Diagnostic odds ratio; CI = Confidence interval; LR = Likelihood ratio. Figure 3Summary receiver operating characteristic (SROC) curve for SWE in the diagnosis of PCa for all studies. AUC = Area under the curve. Figure 4Result of Bayesian analyses showing the pre- and post-test likelihoods for PCa detection. The pre-test probability is the probability of a PCa episode being detected without taking SWE into account. The post-test probability takes into account the results of SWE. LR = Likelihood ratio.

Evaluation of publication bias {#Sec6}
------------------------------

A Deeks' funnel plot was generated to explore the potential for publication bias. Based on the symmetric shape of the funnel plot of the pooled DOR (Fig. [5](#Fig5){ref-type="fig"}) and the Deeks' test non-significant value (p = 0.156), we detected no potential publication bias in this meta-analysis.Figure 5Funnel plot for the evaluation of potential publication bias. Each solid circle represents a study in the meta-analysis. The line is the regression line.

Discussion {#Sec7}
==========

Currently, several methods are used to detect PCa. According to current guidelines^[@CR22]^, diagnosis should include PSA level measurement, DRE and TRUS. However, none of these measurements can provide an optimal diagnosis for PCa because of limitations of each approach. PSA has led to many cases of misdiagnosis due to its high sensitivity but low specificity^[@CR23]^, resulting in many patients with benign lesions undergoing unnecessary biopsy^[@CR23],\ [@CR24]^. DRE has been used as a screening tool for PCa; however, DRE is examiner-dependent method and is limited to the posterior part of the prostate. TRUS is a safe procedure that can provide effective evidence for the detection of PCa. Unfortunately, TRUS is a non-quantitative method that is associated with subjective measurements and largely depends upon the ability of the physician performing the examination; it has a reported sensitivity of 17--57% and specificity of 40--63%^[@CR25]^. Therefore, developing an ideal imaging and detection method for PCa that offers high overall sensitivity and specificity is essential.

An increased cell density of a neoplastic mass leads to changes in tissue elasticity such that the stiffness of normal tissue is significantly different from that of tumor tissue^[@CR26],\ [@CR27]^. Elastography is an imaging technique used for the detection of cancer tissue based on stiffness differences among various tissues^[@CR28]^, and it has been shown to be a useful diagnostic method for many organs, such as the thyroid, breast and prostate^[@CR29]--[@CR31]^. Most studies have reported a remarkable amelioration in PCa identification using elastography^[@CR32],\ [@CR33]^. The sensitivity of elastography for PCa diagnosis can reach or exceed 90%, which is obviously greater than that of PSA, DRE or TRUS^[@CR32],\ [@CR34],\ [@CR35]^. However, traditional elastography also has many limitations, mostly due to the lack of uniform repeatability resulting from manual compression and operator dependency, which can introduce extensive variability^[@CR36]--[@CR38]^.

SWE is a technique that uses a sonographic pulse to produce a shear wave in the tissue^[@CR39],\ [@CR40]^. Tissue stiffness is expressed as the Young's modulus or simply as the ratio of stress generated by tissue deformation^[@CR41]^. A previous study showed no significant difference in intra-observer reproducibility among the measurements stratified by prostate gland volume, patient age, or levels of serum PSA^[@CR42]^. Compared with quasistatic compression elastography, SWE is much closer to a standard TRUS clinical examination because it does not require any additional compression.

Recently, SWE has been shown to be a useful technique for prostate examination^[@CR9],\ [@CR14]--[@CR19],\ [@CR21],\ [@CR42]^. Barr *et al*.^[@CR17]^ reported that SWE showed a high sensitivity of 96.2%, specificity of 96.2%, positive predictive value (PPV) of 69.4%, and negative predictive value (NPV) of 99.6% for the detection of PCa when 37 kPa was used as a cut-off value between benign and malignant lesions. Ahmad *et al*.^[@CR14]^ also showed that the sensitivity and specificity of SWE for PCa detection could each reach 90%. However, Woo *et al*.^[@CR19]^ reported low sensitivity and variable specificity for the diagnostic value of SWE in the detection of PCa, even though the SWE parameters were significantly different between PCa and benign prostate tissues. Additionally, Porsch *et al*.^[@CR21]^ showed that SWE was a poor predictor of malignancy for prostate lesions. Considering these inconsistent results, we believed it necessary to assess the diagnostic value of SWE for the detection of PCa. To the best of our knowledge, this represents the first meta-analysis to evaluate the diagnostic value of SWE for the detection of PCa.

Literature screening was carried out following a strict protocol, and the search ultimately identified 7 relevant studies. Deeks' funnel plots showed no significant publication bias, and according to the QUADAS-2 questionnaire, the 7 studies were of high quality. Our results showed that SWE had a pooled sensitivity of 84.4% and specificity of 86.0% for the detection of PCa; these values are both higher than those obtained for traditional TRUS^[@CR32]^ and real-time elastography for the diagnosis of patients with suspected PCa^[@CR37]^. The AUC (0.91) and DOR (33.069) further indicated perfect overall accuracy. Additionally, the PLR value was 6.017 (95% CI: 3.674--9.853), which was clinically meaningful for our measures of diagnostic accuracy.

Currently, the success rate of systematic prostate biopsy varies from 25% to 30%, whereas its false-negative rate ranges from 17% to 21% in patients with a negative initial series of biopsies^[@CR43],\ [@CR44]^. Real-time quantitative SWE imaging has the potential to change the clinical practice of PCa identification and screening by improving the localization of abnormal foci and allowing limited targeted biopsies of suspicious areas, thereby reducing both complications and costs associated with the current standard of care^[@CR14]^. Although there was no cut-off-value-related heterogeneity in this meta-analysis, it would be of interest to determine whether the measured stiffness or a specific cut-off value predicts up- or down-grading of these regions. This topic could be the subject of future investigations.

A comprehensive literature search and careful data extraction were performed to avoid bias. Nevertheless, limitations exist in our study. First, we did not carry out subgroup analysis of patients with different measurement locations; previous studies have revealed that the location of tumor foci within the prostate gland can influence the detection rate using TRES^[@CR5],\ [@CR16],\ [@CR45],\ [@CR46]^. Although SWE provides much-needed solutions to the ongoing challenge of accurately locating areas of interest in the prostate, it also has the inherent advantage of independence from operator experience and expertise. Second, most studies considered in this meta-analysis used TRUS-guided biopsy data as a reference standard for PCa detection, whereas two studies used histopathology analyses of RP specimens. Although TRUS-guided biopsy is the recommended diagnostic method for most patients suspected of having PCa^[@CR47]^, this method performs poorly in locating PCa compared with histopathology of the RP specimen^[@CR48]^, and SWE estimates also lack strong correlations with PCa location. Third, we failed to acquire unpublished data, and language limitations might have affected the reliability of our results. Fourth, this meta-analysis did not evaluate the correlation between the stiffness value of a lesion and the Gleason score because of a lack of valid data for extraction despite the fact that the Gleason score is one of the most frequently used histologic grading systems for PCa^[@CR49]^.

Based on the findings of this meta-analysis and previous studies, we consider SWE to be a novel and non-invasive imaging technique that is superior to conventional TRUS for the assessment of tissue stiffness to provide information for the detection of PCa and biopsy guidance. The application of SWE might lead to a decrease in the number of biopsy cores. Although SWE does not require any additional compression compared with quasistatic compression elastography and no significant difference in intra-observer reproducibility among the measurements^[@CR42]^, practitioners should be trained in its application, and reference standards should be agreed upon for the location of prostate cancer lesions and histopathology. The Gleason score is one of the most frequently used histologic grading systems for PCa, and the prognosis of PCa is closely related to the Gleason score^[@CR49]^; thus, multicenter studies with a larger number of cases should be conducted to reveal the correlation between the Gleason score and the tissue stiffness of PCa. In addition, a previous study^[@CR50]^ showed that multiparametric MRI (mpMRI) provided the best anatomical and functional imaging of the prostate compared with that of other imaging methods, and a systematic review^[@CR51]^ suggested that mpMRI could be used to trigger a targeted repeat biopsy for prostate cancer diagnosis. Future research should be performed to evaluate the correlations between SWE and mpMRI with histopathology as the gold standard.

In conclusion, this meta-analysis shows that SWE has high sensitivity and specificity for the detection of PCa and is useful for differentiating between malignant and benign prostate lesions. Thus, we believe that SWE could improve the guiding capability and reduce the unnecessary core biopsies required for diagnosis. Further studies with a multicenter design will be needed to assess the role of SWE in the detection of PCa.

Methods {#Sec8}
=======

Search strategy {#Sec9}
---------------

An independent search of the English and Chinese medical literature using the PubMed (Medicine) database and cross-citation with other databases (i.e., Embase, Cochrane Library databases, Web of Science and CNKI) was performed to identify all studies involving diagnostic tests that estimated the value of SWE for the diagnosis of PCa. Searches were conducted using the following key words: elastography, sonoelastography, and elastosonography combined with prostate. Repeated articles were manually excluded. Unpublished relevant data were also considered, but no studies with such data were found that were appropriate for inclusion. This study was performed by two independent authors. The search was updated until October 23, 2016.

Eligibility and exclusion criteria {#Sec10}
----------------------------------

All articles were evaluated independently by two authors. A study was included if it met the following criteria: (1) a cross-sectional study that evaluated the ability of SWE to detect PCa; (2) use of histopathology as a diagnostic standard; and (3) reported data (sensitivity and specificity) necessary to calculate the true-positive, false-negative, false-positive and true-negative rates of SWE in the diagnosis of PCa. All of the included studies should have obtained informed consent from study participants and received protocol approval by an ethics committee or institutional review board. Review articles, conference reports, letters, editorial comments, opinions, prefaces, low-quality studies and articles not published in English or Chinese were excluded. All disagreements were resolved by consensus.

Data extraction {#Sec11}
---------------

All relevant data from the 7 included studies, including first author; year that the study was performed; age of subjects; PSA level; number of patients; number of samples; ultrasound system; cut-off value; and number of true positives, false negatives, false positives and true negatives, were extracted in a unified form. Any divergence from this procedure was resolved by discussion.

Assessments of methodological quality {#Sec12}
-------------------------------------

Methodological quality was evaluated using the revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2)^[@CR52]^ included in a systematic reviews tool. QUADAS-2 classifies risks for bias into four key domains that encompass patient selection, index test, reference standard, flow and timing. Each domain was assessed in terms of the risk of bias, and patient selection, index test, and reference standard were also assessed for applicability. Two authors independently conducted the quality assessment, and any disagreements were resolved by discussion or appeal to a third author.

Statistical analysis {#Sec13}
--------------------

The statistical software package STATA, version 11.0 (Stata Corporation, College Station, TX, USA), and Meta-Disc, version 1.4 for Windows (XI Cochrane Colloquium, Barcelona, Spain), were used in this study. To research possible heterogeneity resulting from the threshold effect, we calculated Spearman correlation coefficients between sensitivity and 1-specificity. The pooled sensitivity, specificity, AUC, PLR, NLR, DOR, and other related indexes were calculated using STATA. Fagan's nomogram was used to visualize the detection of SWE for PCa using likelihood ratios to calculate a post-test probability based on Bayesian theorems. We performed Deeks' funnel plot analysis to check for potential publication bias in our study, with a p*-*value \< 0.1 suggesting statistical significance^[@CR53]^.
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